Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study

Nav

General Info

Geography

China (CHN)

Beijing

Coverage type

Subnational

Time period covered

01/2020 - 12/2022

Data type

Scientific literature

Keywords

Schizophrenia

Citation

Authors

Chen X, Fan Y, Ren W, Sun M, Guan X, Xiu M, Li S

Journal

Front Pharmacol

Volume

Pages

1264591

Publication year

2023

Suggested citation

Chen X, Fan Y, Ren W, Sun M, Guan X, Xiu M, Li S. Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study. Front Pharmacol. 2023; 14: 1264591.

DOI

103389fphar20231264591

PMID

38026922

GHDx Entry last modified on: Mar 25, 2025

Header sites

Search form

Main menu

Baseline BMI is associated with clinical symptom improvements in first-episode schizophrenia: a longitudinal study

Nav